Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer
Tuğba Akın Telli, Giacomo Bregni, Michele Vanhooren, Rita Saude Conde, Alain Hendlisz, Francesco Sclafani
Topics & Concepts
RegorafenibMedicineColorectal cancerMicrosatellite instabilityCancer researchOncologyImmune checkpointInternal medicineCancerMicrosatelliteImmunotherapyGeneticsGeneBiologyAlleleGenetic factors in colorectal cancerColorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers